(Press-News.org) Barcelona, Spain – Sunday 31 August 2014: A new batteryless cardiac pacemaker based on an automatic wristwatch and powered by heart motion was presented at ESC Congress 2014 today by Adrian Zurbuchen from Switzerland. The prototype device does not require battery replacement.
Mr Zurbuchen, a PhD candidate in the Cardiovascular Engineering Group at ARTORG, University of Bern, Switzerland, said: "Batteries are a limiting factor in today's medical implants. Once they reach a critically low energy level, physicians see themselves forced to replace a correctly functioning medical device in a surgical intervention. This is an unpleasant scenario which increases costs and the risk of complications for patients."
At ESC Congress today, Mr Zurbuchen presents a way to power a cardiac pacemaker with an alternative energy source – the heart motion.
Four years ago Professor Rolf Vogel, a cardiologist and engineer at the University of Bern, had the idea of using an automatic wristwatch mechanism to harvest the energy of heart motion. Mr Zurbuchen said: "The heart seems to be a very promising energy source because its contractions are repetitive and present for 24 hours a day, 7 days a week. Furthermore the automatic clockwork, invented in the year 1777, has a good reputation as a reliable technology to scavenge energy from motion."
The researchers' first prototype is based on a commercially available automatic wristwatch. All unnecessary parts were removed to reduce weight and size. In addition, they developed a custom-made housing with eyelets that allows suturing the device directly onto the myocardium (photo 1).
The prototype works the same way it would on a person's wrist. When it is exposed to an external acceleration, the eccentric mass of the clockwork starts rotating. This rotation progressively winds a mechanical spring. After the spring is fully charged it unwinds and thereby spins an electrical micro-generator.
To test the prototype, the researchers developed an electronic circuit to transform and store the signal into a small buffer capacity. They then connected the system to a custom-made cardiac pacemaker (photo 2). The system worked in three steps. First, the harvesting prototype acquired energy from the heart. Second, the energy was temporarily stored in the buffer capacity. And finally, the buffered energy was used by the pacemaker to apply minute stimuli to the heart.
The researchers successfully tested the system in in vivo experiments with domestic pigs. The newly developed system allowed them for the first time to perform batteryless overdrive-pacing at 130 beats per minute.
Mr Zurbuchen said: "We have shown that it is possible to pace the heart using the power of its own motion. The next step in our prototype is to integrate both the electronic circuit for energy storage and the custom-made pacemaker directly into the harvesting device. This will eliminate the need for leads."
He concluded: "Our new pacemaker tackles the two major disadvantages of today's pacemakers. First, pacemaker leads are prone to fracture and can pose an imminent threat to the patient. And second, the lifetime of a pacemaker battery is limited. Our energy harvesting system is located directly on the heart and has the potential to avoid both disadvantages by providing the world with a batteryless and leadless pacemaker."
INFORMATION:
Photo 1: The energy harvesting device is sutured directly onto the myocardium
Photo 2: The batteryless pacemaker was tested by connecting the energy harvesting device to an electronic circuit that transformed and stored the signal into a small buffer capacity. The buffered energy was used to power a custom-made cardiac pacemaker. Electrical stimuli were delivered to the heart by epicardial leads.
Batteryless cardiac pacemaker is based on automatic wristwatch
2014-08-31
ELSE PRESS RELEASES FROM THIS DATE:
AF mortality and morbidity high at 1 year despite good anticoagulant use
2014-08-31
Barcelona, Spain – Sunday 31 August 2014: Mortality and morbidity of atrial fibrillation (AF) patients remains high at one year despite good use of oral anticoagulants, according to the one year follow up of the Atrial Fibrillation General Pilot Registry. The findings were presented for the first time at ESC Congress 2014 today by registry chairperson Professor Gregory Lip (Birmingham, UK).
Professor Lip said: "This is the first contemporary, ESC sponsored registry focused on management practices of European cardiologists conducted since the ESC guidelines on AF were ...
Medication shows mixed results in reducing complications from cardiac surgery
2014-08-30
Administration of colchicine, a plant-based medication commonly used to treat gout, before and after cardiac surgery showed mixed results in reducing potential complications from this type of surgery, but it did increase the risk of gastrointestinal adverse effects, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress.
Common complications after cardiac surgery include postpericardiotomy syndrome (the occurrence of the symptoms of pericarditis, including chest ...
Transvenous lead extraction clinically successful in 98 percent of cases
2014-08-30
Barcelona, Spain – Saturday 30 August 2014: Transvenous lead extraction (TLE) is clinically successful in more than 98% of cases according to data from the European Lead Extraction ConTRolled (ELECTRa) registry presented for the first time today at ESC Congress 2014 by Dr Maria Grazia Bongiorni, chair of the registry's executive committee.
Dr Bongiorni said: "The number of cardiac implantable electronic devices (CIED) implant procedures has grown in recent years. Despite advances in technology the number of complications has increased and leads are often the cause. TLE ...
First multidisciplinary recommendations on management of arrhythmias in ACS patients
2014-08-30
Barcelona, Spain – Saturday 30 August 2014: The first multidisciplinary recommendations on the management of arrhythmias in patients with acute coronary syndromes (ACS) are published today in EP Europace.
The position paper was written jointly by the European Heart Rhythm Association (EHRA), the Acute Cardiovascular Care Association (ACCA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), all of the ESC.
Professor Bulent Gorenek (Turkey), chairperson of the task force, said: "Sudden cardiac death is the leading cause of death in Europe, ...
First expert consensus on ventricular arrhythmias published
2014-08-30
Barcelona, Spain – Saturday 30 August 2014: The first expert consensus on ventricular arrhythmias is published today. The novel document compiles current evidence on the diagnosis and management of ventricular arrhythmias and was agreed by international experts from three continents.
The "EHRA/HRS/APHRS Expert Consensus on Ventricular Arrhythmias" is published today on-line in EP Europace (1). It was written jointly by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC), the Heart Rhythm Society (HRS) and the Asia Pacific Heart Rhythm ...
First comprehensive ESC Guidelines on aortic diseases published
2014-08-30
Barcelona, Spain – Saturday 30 August 2014: The first comprehensive ESC Guidelines on aortic diseases are published today. They are presented at ESC Congress 2014 by Task Force Chairpersons Professor Raimund Erbel (Germany) and Professor Victor Aboyans (France).
The "2014 ESC Guidelines on the diagnosis and treatment of aortic diseases" are published today online in European Heart Journal (1) and on the ESC Website.
Professor Erbel said: "Previous ESC recommendations were published in 2001 but they were restricted to the diagnosis and management of aortic dissection. ...
First recommendations on all new oral anticoagulants in pulmonary embolism published
2014-08-30
Barcelona, Spain – Saturday 30 August 2014: The first recommendations on the use of all new oral anticoagulants in pulmonary embolism are published today in new ESC Guidelines. The guidelines are launched at ESC Congress by Professor Stavros V. Konstantinides (Germany/Greece) and Professor Adam Torbicki (Poland).
The "2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism" are published today online in European Heart Journal (1) and on the ESC Website.
Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE). ...
Sudden death predictor identifies ICD candidates in new ESC Guidelines
2014-08-30
Barcelona, Spain – Saturday 30 August 2014: A new sudden death predictor for patients with hypertrophic cardiomyopathy (HCM) identifies candidates for implantable cardioverter defibrillators (ICDs) in ESC Guidelines published today. They are presented at ESC Congress by Task Force Chairperson Professor Perry Elliott (UK).
The "2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy" are published today on-line in the European Heart Journal (1) and on the ESC Website. Previous ESC Guidelines on hypertrophic cardiomyopathy were published in 2003 (2).
Professor ...
ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD
2014-08-30
Barcelona, Spain – Saturday 30 August 2014: The therapeutic benefit of revascularisation in coronary artery disease (CAD) is emphasised in the 2014 ESC/EACTS revascularisation guidelines presented at ESC Congress by joint Task Force Chairs Professor Stephan Windecker (Switzerland) of the European Society of Cardiology (ESC) and Professor Philippe Kolh (Belgium) of the European Association for Cardio-Thoracic Surgery (EACTS). The joint guidelines are published today on-line in European Heart Journal (1), on the ESC Website (2), in EuroIntervention and in the European Journal ...
The early cost of HIV
2014-08-29
Researchers at UC Davis have made some surprising discoveries about the body's initial responses to HIV infection. Studying simian immunodeficiency virus (SIV), the team found that specialized cells in the intestine called Paneth cells are early responders to viral invasion and are the source of gut inflammation by producing a cytokine called interleukin-1 beta (IL-1β).
Though aimed at the presence of virus, IL-1β causes breakdown of the gut epithelium that provides a barrier to protect the body against pathogens. Importantly, this occurs prior to the wide ...